| Integrated genomic characterization of IDH1-mutant glioma malignant progression H Bai, AS Harmancı, EZ Erson-Omay, J Li, S Coşkun, M Simon, ... Nature genetics 48 (1), 59-66, 2016 | 315 | 2016 |
| Integrated genomic analyses of de novo pathways underlying atypical meningiomas AS Harmancı, MW Youngblood, VE Clark, S Coşkun, O Henegariu, ... Nature communications 8 (1), 14433, 2017 | 202* | 2017 |
| Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series LD Kaulen, S Doubrovinskaia, C Mooshage, B Jordan, J Purrucker, ... European journal of neurology 29 (2), 555-563, 2022 | 120 | 2022 |
| Primary dural lymphomas: clinical presentation, management, and outcome P Karschnia, TT Batchelor, JT Jordan, B Shaw, SF Winter, FJ Barbiero, ... Cancer 126 (12), 2811-2820, 2020 | 33 | 2020 |
| Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma LD Kaulen, D Galluzzo, P Hui, F Barbiero, P Karschnia, A Huttner, ... Journal of Neuro-Oncology 144, 107-115, 2019 | 25 | 2019 |
| Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2): A follow‐up study S Doubrovinskaia, CM Mooshage, C Seliger, HM Lorenz, S Nagel, ... European journal of neurology 30 (2), 463-473, 2023 | 19 | 2023 |
| Autoimmune disease-related primary CNS lymphoma: systematic review and meta-analysis LD Kaulen, P Karschnia, J Dietrich, JM Baehring Journal of Neuro-Oncology 149, 153-159, 2020 | 16 | 2020 |
| Exome sequencing identifies SLIT2 variants in primary CNS lymphoma LD Kaulen, EZ Erson‐Omay, O Henegariu, P Karschnia, A Huttner, ... British Journal of Haematology 193 (2), 375-379, 2021 | 12 | 2021 |
| Pleiotropic role of TRAF7 in skull-base meningiomas and congenital heart disease K Mishra-Gorur, T Barak, LD Kaulen, O Henegariu, SC Jin, SM Aguilera, ... Proceedings of the National Academy of Sciences 120 (16), e2214997120, 2023 | 8 | 2023 |
| Metabolic heterogeneity of brain tumor cells of proneural and mesenchymal origin C Seliger, AL Meyer, V Leidgens, L Rauer, S Moeckel, B Jachnik, ... International journal of molecular sciences 23 (19), 11629, 2022 | 8 | 2022 |
| Primary CNS lymphoma after CLIPPERS: a case series S Doubrovinskaia, F Sahm, MC Thier, M Bendszus, W Wick, C Seliger, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (12), 1348-1349, 2021 | 8 | 2021 |
| Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experience P Karschnia, FJ Barbiero, MH Schwaiblmair, LD Kaulen, JM Piepmeier, ... Neuro-Oncology Practice 7 (1), 118-126, 2020 | 8 | 2020 |
| Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat Commun 8: 14433 AS Harmanci, MW Youngblood, VE Clark, S Coskun, O Henegariu, ... | 7 | 2017 |
| Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial T Kessler, D Schrimpf, L Doerner, L Hai, LD Kaulen, J Ito, M van den Bent, ... Clinical Cancer Research 29 (19), 3892-3900, 2023 | 4 | 2023 |
| Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma LD Kaulen, C Gumbinger, F Hinz, T Kessler, F Winkler, M Bendszus, ... Neuro-Oncology Advances 4 (1), vdac051, 2022 | 4 | 2022 |
| Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus-(EBV) positive primary CNS lymphomas LD Kaulen, E Denisova, F Hinz, L Hai, D Friedel, O Henegariu, ... Acta neuropathologica 146 (3), 499-514, 2023 | 3 | 2023 |
| Genomic alterations in Turcot syndrome: Insights from whole exome sequencing P Karschnia, EZ Erson-Omay, AJ Huttner, LD Kaulen, D Duran, ... Journal of the Neurological Sciences 417, 2020 | 2 | 2020 |
| Neurolymphomatosis of the thoracic sympathetic chain LD Kaulen, FM Foss, RK Fulbright, A Huttner, JM Baehring Neurology 89 (18), 1926-1927, 2017 | 2 | 2017 |
| Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma F Iser, F Hinz, DC Hoffmann, N Grassl, C Güngör, J Meyer, L Dörner, ... Clinical Cancer Research, OF1-OF12, 2024 | 1 | 2024 |
| A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1 L Hai, DC Hoffmann, RJ Wagener, DD Azorin, D Hausmann, R Xie, ... Nature Communications 15 (1), 968, 2024 | 1 | 2024 |
